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Summary 
Cells in the rheumatoid synovium express high levels of major histocompatibility complex (MHC) 
class II molecules in vivo. We have therefore examined the ability of engagement of MHC class 
II molecules by the superantigen Staphylococcal  enterotoxin A (SEA) to activate interleukin 6 
(IL-6) and ILo8 gene expression in type B synoviocytes isolated from patients with rheumatoid 
arthritis. SEA had a minimal or undetectable effect on the expression of either gene in resting 
synoviocytes, as determined by Northern blot and specific enzyme-linked immunosorbent assay. 
However, induction of MHC class II molecule expression after treatment of synoviocytes with 
interferon 3' (IFN-3') enabled the cells to respond to SEA in a dose-dependent manner, resulting 
in an increase in both the level of steady-state mRNA for IL-6 and IL-8, and the release of these 
cytokines into the supernatant. IFN-3' by itself had no effect on the expression of either cytokine. 
Pretreatment of the cells with the transcription inhibitor actinomycin D prevented the increase 
in cytokine mRNA induced by ~fEA, whereas cycloheximide superinduced mRNA for both 
cytokines after stimulation by SEA. Taken together, these results indicate that signaling through 
MHC class II molecules may represent a novel mechanism by which inflammatory cytokine 
production is regulated in type B rheumatoid synoviocytes, and potentially provides insight into 
the manner by which superantigens may initiate and/or propagate autoimmune diseases. 
heumatoid arthritis (RA) is a chronic articular inflam- 
matory disorder in which the synovial environment is 
characterized by intense immunological activity (1). In par- 
ticular, the macrophage-like (type A) and fibroblast-like (type 
B) synoviocytes of the hyperplastic lining layer exhibit an ac- 
tivated phenotype. Both cell types express a high level of MHC 
class II molecules (1), which are involved in the initial step 
of the immune response (2), and these cells are a major source 
of several inflammatory cytokines, which also are believed to 
play a crucial  role in the pathogenesis of RA (1). 
Using superantigens such as Staphylococcal enterotoxins 
A or B (SEA or SEB), toxic shock syndrome toxin 1 (TSST- 
1), or mAbs that bind to various epitopes on the MHC class 
II molecule (3, 4), a number of reports have addressed the 
possibility that upon engagement, MHC class II molecules 
on APC (B cells and monocytes) may act as signal transduc- 
tion molecules. For example,  activation of B cells with an 
anti-MHC class II antibody stimulated translocation of pro- 
tein kinase C  (PKC)  and a rise in intracellular cAMP levels 
(5). Binding of TSST-1 to MHC class II molecules also triggers 
human B cell proliferation and differentiation via MHC class 
II-unrestricted cognate T-B cell interaction (6). We have also 
reported that TSST-1 induces sustained LFA-l-dependent adhe- 
sion of MHC class II-positive cells (7) and delivers a comito- 
genic signal to human B cells primed with PMA or anti-IgM 
(8). In addition, it has recently been reported that treatment 
of human monocytes and monocytic cell lines with TSST-1 
and SEB induces an upregulation of the genes for I1.-1 and 
TNF-o~ (9). 
In view of the potentially important role of ID6 and IL-8 
in the pathogenesis of rheumatoid arthritis (1), and Of their 
immunological effects in vitro and in vivo, we have charac- 
terized the ability of engagement of MHC class II molecules 
on synoviocytes  to modulate the expression  of these two 
cytokines. Our results indicate that the interaction of SEA 
with MHC class II molecules on synoviocytes results in the 
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Volume 175  February 1992  613-616 Figure 1.  The effect of SEA on II.-6 and Ib8 mRNA levels in human 
rheumatoid  synoviocytes. Subconfluent  synoviocytes were incubated for 
48 h with 200 U/ml IFN-3' or its diluent followed by increasing concen- 
trations  of SEA for a further 6 h.  The cells were then harvested, cyto- 
plasmic RNA was purified, and Northern blots were performed to detect 
mRNA for IL-6 and IL-8. The fihers were also hybridized with a y-actin 
probe as a control. This autoradiogram  is from one experiment,  which 
is representative of three  others  performed  with  similar results. 
upregulation of IL-6 and Ib8 gene transcription and protein 
secretion, and this regulation occurs independently of prior 
protein synthesis. 
Materials  and  Methods 
Reagents.  SEA and SEB were purchased from Toxin Technology 
(Madison,  WI). No LPS was detected when the preparation was 
tested by the Limuhs amoebocyte Lysate (LAL) test (sensitivity, <1 
ng/ml), mAb L243, directed against a monomorphic determinant 
on human  HLA-DR molecules,  was generated from hybridoma 
cells (American Type Culture CoUection, Bethesda, MD). Human 
rIFN-3~ was obtained from Amgen Biologicals (Thousand Oaks, 
CA). 
Synoviocyte Culture.  The synoviocyte cultures used in this study 
were derived from different patients with rheumatoid arthritis un- 
dergoing total knee replacement due to joint deterioration essen- 
Figure 2.  The effect  of actinomycin  D and cycloheximide  on SEA-induced 
Ib6 and IL-8  mRNA in human rheumatoid  synoviocytes. Subconfluent 
synoviocytes were pretreated with IFN-3, for 48 h, followed by a 1-h treat- 
ment with either cycloheximide (10/zg/ml) or actinomycin D (1 #g/ml) 
before being  stimulated  for 6 h with SEA (2.5/zg/ml).  The cells were 
then harvested, cytoplasmic RNA was purified and Northern blots were 
performed as described in the legend to Fig. 1. This autoradiogram is from 
one experiment,  which is representative of three others performed with 
similar results. 
tially as previously described (10).  All patients  were diagnosed as 
suffering from either definite or classical RA according to the Amer- 
ican Rheumatism Association 1987 criteria (11). Ceils used during 
this study were obtained after four to eight passages, morphologi- 
call),, resembled the previously reported "fibroblast-like" synovio- 
cytes, and were Mo-1 and MHC class II negative,  the latter indi- 
cating the absence of type A  or "macrophage-like"  synoviocytes. 
The cells  were cultured  in  DMEM containing  10%  FCS. 
ELISAsfor 11-.6 and IL-8.  Synoviocytes were grown in 96-well 
microtiter plates and treated as described in the figure legends. IL-6 
was measured  using  a  standard  sandwich  ELISA purchased as a 
kit from R&D Systems (Minneapolis, MN). Ib8 levels were deter- 
mined using a sandwich ELISA developed at Genentech Inc. (South 
San Francisco, CA). All experiments were performed in triplicate 
and repeated  on at  least  three occasions on different cultures. 
Northern Blot.  The synoviocytes were grown in tissue culture 
flasks  and treated as described in the figure legends.  Cytoplasmic 
RNA was purified  using a previously described  method (12).  10 
/~g of RNA was loaded onto 1% agarose gels. Equal loading and 
RNA integrity were confirmed by ethidium bromide staining. The 
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Figure 3.  The effect of SEA on the 
synthesis  of IL-6 and  IL-8 by human 
rheumatoid synoviocytes. Subconfluent 
synoviocytes grown in 96-well micro- 
titer plates were incubated as described 
in the legend to Fig. 1 and stimulated 
with increasing concentrations of SEA 
for 12 h.  The supernatants  were then 
collected and analyzed for the presence 
of  immunoreactive  IL-6 and  IL-8. 
Results  are the mean  +  SD of tripli- 
cate determinations from one represen- 
tative experiment. 
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bridized with random primer-labeled  cDNA probes for Ib6 and 
IIr  The  human IL-8 cDNA  probe was  a  244-bp fragment 
representing  the coding  region of the IL-8 cDNA from nucleotides 
49-293 (13). A 1.2-kb human Ib6 cDNA probe was a generous 
gift from the Genetics  Institute (Cambridge, MA). Equal loading 
of RNA was also confirmed  by hybridization  with a 3,-actin  cDNA 
probe (a generous gift from Dr. J. Thibodeau, CHUL Research 
Center, Quebec,  Canada). All washes  were  performed  under strin- 
gent conditions. The mRNA hybridizing  with the two cytokine 
cDNA probes was visualized by autoradiography. 
Results and Discussion 
Subconfluent human rheumatoid synoviocytes were pre- 
treated with either 200 U/ml IFN-y or its diluent (0.1% 
BSA) for 48 h. Standard FACS  |  analysis for the surface ex- 
pression of MHC dass II molecules using a mAb directed 
against HLA-DR revealed maximal induction of MHC class 
II antigens under these conditions,  as had previously been 
reported (14). This treatment has no detectable effect on cell 
proliferation  (14). After preincubation  with IFN-3, or its 
diluent, the cells were treated with increasing concentrations 
of SEA for a further 6 h, and the level of steady-state mRNA 
for IL-6 and II:8 was determined (Fig. 1). More detailed time 
course studies revealed maximal induction of mtLNA at this 
time point (data not shown). No mRNA for IL-8 was de- 
tected in response to SEA when the cells were not pretreated 
with INF-% In contrast, a low level of IL-6 mRNA was de- 
tected in non-INF-'y-treated synoviocytes  when the ceUs  were 
incubated with 5 ~g/ml of SEA, a result supporting the fact 
that a minor expression of MHC class II was observed in 
resting synoviocytes. However, after treatment with INF-% 
a dose-dependent stimulation by SEA of the level of mRNA 
for both IL-6 and IL-8 was observed. The failure of SEA to 
induce a significant response in untreated synoviocytes sup- 
ports the hypothesis that MHC class II molecule expression 
is required for cellular activation by SEA. This conclusion 
is further supported by the fact that stimulation of INF-3'- 
treated synoviocytes with the anti-MHC class II mAb L243 
or with a related enterotoxin (SEB) induced the same response 
(McColl  et al., manuscript in preparation). 
Studies using the transcription inhibitor actinomycin D 
and the protein synthesis inhibitor cycloheximide were also 
conducted in order to determine the level at which SEA was 
activating  the  cytokine genes.  The  cells were  therefore 
pretreated with IFN-3' for 48 h, followed by a further incu- 
bation with either actinomycin D, cycloheximide, or diluent. 
They were then incubated  with either SEA or diluent for 
6 h and the cells were harvested and cytoplasmic R.NA was 
purified for Northern blot analysis (Fig. 2). No mRNA for 
either IL-6 or Ib8 was observed in the synoviocytes that were 
not treated with SEA. In addition, actinomycin D completely 
inhibited the induction of mRNA by SEA, whereas cyclo- 
heximide superinduced the mRNA for both Ib6 and Ib8 
when the cells were stimulated with SEA. Taken together, 
these results indicate that SEA activates IL-6 and 1I.-8 gene 
expression by stimulating transcription of the respective genes 
for these two cytokines and suggest that translation  of the 
mRNA is also occurring. 
To confirm the latter point, we conducted experiments to 
determine the level of secretion of Ib6 and IL-8 in response 
to SEA. Synoviocytes were therefore plated into 96-well mi- 
crotiter plates and pretreated for 48 h with either IFN-~/or 
its diluent. They were then stimulated with increasing con- 
centrations of SEA for 12 h. The supernatants were then col- 
lected and analyzed for Ib6 and Ib8 content by specific  ELISA 
(Fig. 3). Very little release of either Ib6 or IL-8 was observed 
in the non-IFN-3,-treated synoviocytes. In contrast, SEA 
stimulated a dose-dependent release  of  both IL-6 and IL-8 when 
the synoviocytes were pretreated with IFN-3,. A consistent 
stimulatory effect of SEA was first observed at 2.5/~g/ml, 
and increased to be maximal at between 5 and 10 #g/ml for 
II--6 release, whereas IL-8 release was still increasing with 10 
#g/ml of SEA, the highest concentration used in these ex- 
periments.  Pretreatment of the cells with either cyclohexi- 
mide or actinomycin D inhibited the release of both IL-6 and 
Ib8 in SEA-stimulated fibroblasts (data not shown). 
In the present study, incubation  of rheumatoid synovio- 
cytes with SEA, a specific MHC class II ligand,  had little 
or no detectable effect in resting cells. However, induction 
of MHC class II molecule expression on the synoviocyte sur- 
face rendered them responsive to activation by SEA, leading 
to upregulation of the genes for IL-6 and Ib8. These results 
provide evidence  for a role of  MHC class II molecules in medi- 
ating intracellular signaling events. In addition, the fact that 
cytokine gene expression in rheumatoid synoviocytes  was up- 
regulated in response to MHC class II receptor ligation indi- 
cates that the latter molecules could play an important role 
in amplifying the inflammatory cycle in RA. Recent infor- 
mation suggests that the modulation of Ib6 and IL-8 gene 
expression by MHC class II molecules is likely to occur in 
vivo. Firstly, RA is a disease in which the ceils of the syno- 
vium exhibit a high level of MHC class II molecule expres- 
sion (1). Second, recent studies have indicated that molecules 
that could activate MHC class II-mediated signal transduc- 
tion events may also be present in the synovial environment. 
For instance, the presence of a superantigen  that is respon- 
sible for the VB14 T cell oligoclonality observed in RA has 
recently been reported (15). In addition,  antibodies directed 
against the Epstein-Barr virus gp110 glycoprotein, which also 
recognize specific  sequences  in the B chain of  HLA-DR4 MHC 
class II molecules, have  been found in patients with RA (16). 
Therefore, engagement of MHC class II molecules may rep- 
resent an important mechanism by which cytokine gene ex- 
pression is controlled in the rheumatoid synovium. 
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